Total Payments
$75,498
2024 Payments
$442.60
Companies
33
Transactions
579
Medicare Patients
2,263
Medicare Billing
$512,330
Payment Breakdown by Category
Other$42,866 (56.8%)
Food & Beverage$12,857 (17.0%)
Travel$10,418 (13.8%)
Consulting$9,355 (12.4%)
Education$1.06 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $37,416 | 20 | 49.6% |
| Food and Beverage | $12,857 | 518 | 17.0% |
| Travel and Lodging | $10,418 | 33 | 13.8% |
| Consulting Fee | $9,355 | 4 | 12.4% |
| Honoraria | $5,450 | 3 | 7.2% |
| Education | $1.06 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Pernix Therapeutics Holdings, Inc. | $55,182 | 101 | $0 (2019) |
| Boston Scientific Corporation | $4,898 | 256 | $0 (2024) |
| ARBOR PHARMACEUTICALS, INC. | $4,247 | 20 | $0 (2021) |
| Currax Pharmaceuticals LLC | $3,697 | 6 | $0 (2020) |
| Depomed, Inc. | $3,391 | 13 | $0 (2017) |
| ABBVIE INC. | $1,125 | 51 | $0 (2024) |
| PFIZER INC. | $521.27 | 27 | $0 (2024) |
| Daiichi Sankyo Inc. | $402.25 | 18 | $0 (2019) |
| IDORSIA PHARMACEUTICALS US INC | $231.85 | 13 | $0 (2023) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $197.12 | 6 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $442.60 | 24 | ABBVIE INC. ($358.22) |
| 2023 | $1,341 | 55 | ABBVIE INC. ($582.03) |
| 2022 | $744.48 | 35 | Biohaven Pharmaceutical Holding Company Ltd. ($173.17) |
| 2021 | $404.17 | 30 | BOSTON SCIENTIFIC CORPORATION ($208.26) |
| 2020 | $4,279 | 32 | Currax Pharmaceuticals LLC ($3,500) |
| 2019 | $2,212 | 104 | Boston Scientific Corporation ($1,315) |
| 2018 | $22,661 | 130 | Pernix Therapeutics Holdings, Inc. ($20,663) |
| 2017 | $43,412 | 169 | Pernix Therapeutics Holdings, Inc. ($34,277) |
All Payment Transactions
579 individual payment records from CMS Open Payments — Page 1 of 24
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $13.13 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 10/07/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $27.80 | General |
| Category: NEUROSCIENCE | ||||||
| 10/02/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $7.51 | General |
| Category: NEUROSCIENCE | ||||||
| 09/19/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $27.78 | General |
| Category: NEUROSCIENCE | ||||||
| 09/09/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $7.98 | General |
| Category: NEUROSCIENCE | ||||||
| 09/04/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $19.18 | General |
| Category: General - Pain Management_NMD | ||||||
| 08/28/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $24.03 | General |
| Category: PAIN | ||||||
| 08/21/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $6.30 | General |
| Category: NEUROSCIENCE | ||||||
| 08/19/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $7.46 | General |
| Category: NEUROSCIENCE | ||||||
| 08/07/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $28.04 | General |
| Category: PAIN | ||||||
| 07/29/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $28.78 | General |
| Category: NEUROSCIENCE | ||||||
| 07/24/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $25.88 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 07/22/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $22.74 | General |
| Category: NEUROSCIENCE | ||||||
| 06/17/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $26.17 | General |
| Category: NEUROSCIENCE | ||||||
| 05/06/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $34.56 | General |
| Category: NEUROSCIENCE | ||||||
| 04/22/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $30.33 | General |
| Category: NEUROSCIENCE | ||||||
| 04/18/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $9.53 | General |
| Category: NEUROSCIENCE | ||||||
| 04/03/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $23.73 | General |
| Category: NEUROSCIENCE | ||||||
| 03/27/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $5.68 | General |
| Category: NEUROSCIENCE | ||||||
| 03/06/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $7.03 | General |
| Category: NEUROSCIENCE | ||||||
| 02/05/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $19.07 | General |
| Category: NEUROSCIENCE | ||||||
| 01/24/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $24.98 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 01/24/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $7.54 | General |
| Category: NEUROSCIENCE | ||||||
| 01/02/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $7.37 | General |
| Category: NEUROSCIENCE | ||||||
| 12/14/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $34.15 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 400 | 1,890 | $190,966 | $106,254 |
| 2022 | 8 | 563 | 2,201 | $233,519 | $134,887 |
| 2021 | 9 | 634 | 2,377 | $260,485 | $147,214 |
| 2020 | 10 | 666 | 2,503 | $341,927 | $123,975 |
Total Patients
2,263
Total Services
8,971
Medicare Billing
$512,330
Procedure Codes
34
All Medicare Procedures & Services
34 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 180 | 1,486 | $146,230 | $85,967 | 58.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 80 | 115 | $17,250 | $9,026 | 52.3% |
| 62327 | Insertion of tube and injection of substance into lower spine canal using imaging guidance | Office | 2023 | 31 | 44 | $21,120 | $8,254 | 39.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 29 | 29 | $3,625 | $1,990 | 54.9% |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Office | 2023 | 29 | 140 | $2,100 | $706.48 | 33.6% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2023 | 23 | 34 | $578.00 | $297.55 | 51.5% |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | Office | 2023 | 28 | 42 | $63.00 | $13.62 | 21.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 200 | 1,352 | $128,440 | $78,460 | 61.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 175 | 445 | $66,750 | $40,787 | 61.1% |
| 62327 | Insertion of tube and injection of substance into lower spine canal using imaging guidance | Office | 2022 | 36 | 46 | $22,080 | $8,620 | 39.0% |
| 62321 | Injection of substance into middle or upper spine canal using imaging guidance | Office | 2022 | 12 | 16 | $7,680 | $3,169 | 41.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 37 | 37 | $4,625 | $2,466 | 53.3% |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Office | 2022 | 41 | 210 | $3,150 | $1,034 | 32.8% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2022 | 25 | 42 | $714.00 | $337.87 | 47.3% |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | Office | 2022 | 37 | 53 | $79.50 | $13.10 | 16.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 234 | 1,739 | $165,205 | $104,288 | 63.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 147 | 252 | $37,745 | $22,071 | 58.5% |
| 62327 | Insertion of indwelling catheter and administration of substance into spinal canal of lower back lower back using imaging guidance | Office | 2021 | 34 | 57 | $27,360 | $10,759 | 39.3% |
| 62321 | Injection of substance into spinal canal of upper or middle back using imaging guidance | Office | 2021 | 19 | 24 | $11,520 | $4,588 | 39.8% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 38 | 38 | $4,750 | $2,900 | 61.0% |
| 95972 | Electronic analysis of implanted brain, spinal cord or peripheral stimulation device with complex spinal cord or peripheral nerve stimulator programming | Office | 2021 | 25 | 27 | $9,450 | $956.78 | 10.1% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2021 | 68 | 118 | $2,006 | $864.10 | 43.1% |
| 20605 | Aspiration and/or injection of medium joint or joint capsule | Office | 2021 | 18 | 23 | $2,300 | $765.53 | 33.3% |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | Office | 2021 | 51 | 99 | $148.50 | $22.40 | 15.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 228 | 1,707 | $162,165 | $81,748 | 50.4% |
About Dr. Hugh Maddox, M.D
Dr. Hugh Maddox, M.D is a Pain Medicine healthcare provider based in Anniston, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/29/2005. The National Provider Identifier (NPI) number assigned to this provider is 1073590170.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Hugh Maddox, M.D has received a total of $75,498 in payments from pharmaceutical and medical device companies, with $442.60 received in 2024. These payments were reported across 579 transactions from 33 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($37,416).
As a Medicare-enrolled provider, Maddox has provided services to 2,263 Medicare beneficiaries, totaling 8,971 services with total Medicare billing of $512,330. Data is available for 4 years (2020–2023), covering 34 distinct procedure/service records.
Ad
Practice Information
- Specialty Pain Medicine
- Other Specialties Pain Medicine, Pain Medicine
- Location Anniston, AL
- Active Since 12/29/2005
- Last Updated 10/25/2007
- Taxonomy Code 207LP2900X
- Entity Type Individual
- NPI Number 1073590170
Products in Payments
- ZOHYDRO ER (Drug) $58,370
- Horizant (Drug) $4,247
- Gralise (Drug) $3,264
- SPECTRA WAVEWRITER (Device) $1,776
- UBRELVY (Drug) $551.11
- INFINION (Device) $508.00
- GENERAL - PAIN MANAGEMENT (Device) $494.16
- SILENOR (Drug) $414.24
- QULIPTA (Drug) $412.11
- GENERAL PAIN MANAGEMENT (Device) $348.05
- GENERAL PAIN MANAGEMENT (Device) $304.19
- SPECTRA SYSTEM (Device) $300.70
- NURTEC ODT (Drug) $261.72
- WaveWriter Alpha Prime 16 (Device) $255.27
- Movantik (Drug) $254.92
- CLINICAL TRIAL PRODUCT (Device) $233.12
- QUVIVIQ (Drug) $231.85
- LYRICA (Drug) $201.43
- Morphabond ER (Drug) $171.17
- BOTOX (Biological) $161.90
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.